The Earthtimes online News
Home

'Take Darvon and generic versions off US market', FDA petitioned

Consumer group Public Citizen yesterday petitioned the US Food and Drug Administration to withdraw the leading painkiller Darvon and its generic versions from the market. The group said the drug was linked to more 2000 deaths, is highly addictive and less effective than safer alternatives that were available.
Posted : Thu, 02 Mar 2006 00:10:04 GMT
Author : Geoffrey Lewis
Category : Health
News Alerts by Email ( click here )
Create your own RSS
Health News | Home
Consumer group Public Citizen yesterday petitioned the US Food and Drug Administration to withdraw the leading painkiller Darvon and its generic versions from the market. The group said the drug was linked to more 2000 deaths, is highly addictive and less effective than safer alternatives that were available.

In its petition, the group explains that propoxyphene, selling under brand names such as Darvon, Darvocet, etc., is the 12th most commonly prescribed drug in the US. In 2004 alone, US pharmacies had filled a total of 23 million propoxyphene-based prescriptions. The drug is blamed for 2,110 - i.e. 5.6 percent of all drug-related deaths between 1981 and 1999.

When used, the drug gets converted into a highly toxic agent norpropoxyphene that stays longer in the system and causes the patient's heartbeat to slow. It can even cause cardiac depression, cardiac arrest or other complications, the group's petition said.

Competent physicians were aware of the drug's flaws and do not prescribe this drug, the group said. It had first urged the FDA to withdraw the same drug in the 1970s but the federal agency's inaction for so many years prompted the group to petition again.

They said the drug's withdrawal from the market should be gradual – in phases, to allow patients who use the drug enough time to switch to a safer alternative under the direction of their doctors. Many patients had already become dependent on the drug, the group said, and phasing out its withdrawal would ease the transition to another therapy.

The group cited similar withdrawal of the drug from the UK markets by the British government. Dr Sidney Wolfe, director of the group's Health Research division, said there was “no excuse for the drug to be around”.

The group supported its petition with autopsy statistics from the U.S. Drug Abuse Warning Network. The drug is particularly dangerous for the elderly as it affected their nervous system much like a sedative, which often resulted in the patient feeling confused and becoming prone to accidents like slipping and falling down, which can be fatal because of their fragile aging bones.

The drug was also linked to hundreds of suicides.

Copyright, respective author or news agency



Article : 'Take Darvon and generic versions off US market', FDA petitioned
Print this article
Email this article

Stay Updated
News gadget on your Google homepage
Subscribe to a news feed in Google Reader

Share on

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 

 
Your Comments

Darvon
By: Larry Robbins , Sun, 05 Mar 2006 23:12:01 GMT

This reporting on Darvon is ridiculously one-sided. Darvon is an interesting that has been known to cause strong reactions in some people and mild in others. In some cases it has been effective in eliminating the desire to consume alcohol (not it's intended purpose). Some individuals simply can not take Darvon and others take it regularly, several times a day for long periods with no side effects. For those people who derive benefit from Darvon, it's effects are unique. There are many reasons to keep Darvon on the market if used properly. This campaign to eliminate it is totally irresponsible



More Health News click here

Choose Theme
Green Earth Blue Earth Orange Earth Purple Earth

Search
 
You can
Print this articleemail this articleComment on this article

Current News

News Category
Business
Entertainment
Environment
General
Health
Sports
Technology
World
Press Release
Add to Google Toolbar
Breaking News
Press Releases

About us | News Archives | Browse old Archive | Feedback | Disclaimer | Mobile/PDA | News Alerts

The views expressed in the articles are not necessarily those of earthtimes.org and we accept no responsibility for the views or opinions
expressed in the articles either direct or indirect.

© 2008 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy